Martin Louis Wilson - 14 Feb 2024 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role: General Counsel
Signature: /s/ Martin Louis Wilson
Issuer symbol: RCKT
Transactions as of: 14 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 16 Feb 2024, 16:05:43 UTC
Previous filing: 16 Feb 2023
Next filing: 21 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCKT	Common Stock	Options Exercise	$0	-9,712	-50%	$0.000000	9,712	14 Feb 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCKT	Restricted Stock Units	Options Exercise	$0	-9,712	-33%	$0.000000	19,367	14 Feb 2024	Common Stock	9,712		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.
F2	Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3	One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.